Federation for Innovative Drug Research Netherlands (FIGON) invites people for a summer afternoon on modulating complex disease pathways by novel concepts in drug therapy.
Are you interested in drug development? Come join us at the Centre for Human Drug Research.
Program Overview:
-
Time Slot | Speaker | Topic
13:30–13:35 | Prof. Laura Heitman
FIGON Co-chair; Leiden University | Opening13:35–13:50 | Prof. Laura Heitman
FIGON Co-chair; Leiden University | Introduction to the Federation for Innovative Drug Research Netherlands (FIGON), and its partners13:50–14:20 | Matthijs Moerland
CHDR, Leiden | Translational drug development for immune-targeted drugs; preclinical and clinical models paving the route to patients14:20–14:50 | Nicole Datson
Vico Therapeutics, Leiden | Oligonucleotide-based treatment options in neurological disorders: a journey in Huntington’s disease14:50–15:20 | Bart Klein
ProQR, Leiden | Innovative drug therapy using the Axiomer™ technology concept15:20–15:40 | Tea/coffee break
15:40–15:55 | Yvette Schipper
Lygature; RSNN, Utrecht | Introduction to Regulatory Science Network Netherlands (RSNN)15:55–16:15 | Stan van Belkum
Central Committee on Research Involving Human Subjects (CCMO), The Hague | Expert Meeting Clinical Research in the Netherlands16:15 – 16:45 | Francisco Hernandez AstraZeneca; ATMP Special Interest Group | Advanced Therapy Medicinal Product (ATMP) Special Interest Group case example
16:45–16:50 | Prof. Laura Heitman | Closing
16:00–20:00 | Life Sciences Café by the Leiden Bio Science Park
Location: Grand Café De Stal
Seating is limited. To reserve your spot and receive further FIGON news, e-mail ‘DMSA yes’ to ewoud-janvan.hoogdalem@iconplc.com
